Durlobactam in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections: A Systematic Review

A. baumannii is a frequent cause of difficult-to-treat healthcare-associated infections. The use of a novel beta-lactamase inhibitor, durlobactam, has been proposed against multidrug-resistant A. baumannii. A systematic review of studies assessing the efficacy and safety of durlobactam in the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Guido, Taglietti, Fabrizio, Schiavone, Francesco, Petrosillo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225462/
https://www.ncbi.nlm.nih.gov/pubmed/35743328
http://dx.doi.org/10.3390/jcm11123258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225462/
https://www.ncbi.nlm.nih.gov/pubmed/35743328
http://dx.doi.org/10.3390/jcm11123258

Ejemplares similares